Lymphoblastic lymphoma is a type of aggressive non-Hodgkin lymphoma characterized by the proliferation of immature lymphoid cells. It primarily affects lymph nodes in the inguinal region and lower limbs, leading to significant clinical manifestations. Accurate coding with ICD-10 Code C83.55 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat this serious condition.
ICD-10 Code C83.55 specifically denotes lymphoblastic lymphoma affecting the lymph nodes in the inguinal region and lower limbs. This condition is a subtype of non-Hodgkin lymphoma, often presenting with lymphadenopathy and systemic symptoms. The code should be utilized in clinical documentation and billing when diagnosing patients with this specific type of lymphoma to ensure accurate treatment and reimbursement.
Lymphoblastic lymphoma, nodes of ing region and lower limb, is a hematological malignancy characterized by the uncontrolled growth of immature lymphocytes. It typically presents in adolescents and young adults and requires prompt medical intervention due to its aggressive nature. The condition can lead to significant morbidity if not treated effectively.
In SOAP notes, ICD-10 Code C83.55 is utilized to document the diagnosis of lymphoblastic lymphoma affecting the inguinal region and lower limbs. This code aids in capturing the patient's symptoms, assessment findings, and treatment plans, ensuring comprehensive documentation in both acute and chronic care settings.
ICD-10 Code C83.55 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of lymphoblastic lymphoma. This code is crucial for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Lymphoblastic lymphoma requires urgent medical intervention, often necessitating hospitalization for intensive treatment.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C83.55 is critical for accurate billing in hospital, ER, or infectious disease care settings.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push, single or initial substance. |
| 36415 | Collection of venous blood by venipuncture. |
| 85025 | Complete blood count (CBC) with automated differential. |
| 99223 | Initial hospital care, typically 70 minutes or more. |
Common Questions About Using ICD-10 Code C83.55 for Lymphoblastic lymphoma, nodes of ing region and lower limb
What are the common symptoms of lymphoblastic lymphoma?
Common symptoms include swollen lymph nodes, fever, night sweats, and unexplained weight loss. Patients may also experience fatigue and recurrent infections due to compromised immunity.
How is lymphoblastic lymphoma diagnosed?
Diagnosis typically involves a combination of physical examination, imaging studies, and biopsy of affected lymph nodes to confirm the presence of immature lymphoid cells.
What is the treatment for lymphoblastic lymphoma?
Treatment usually consists of intensive chemotherapy regimens, and in some cases, stem cell transplantation may be considered. Supportive care is also crucial to manage side effects.
Is lymphoblastic lymphoma contagious?
No, lymphoblastic lymphoma is not contagious. It is a malignancy that arises from genetic mutations in lymphocytes and is not spread from person to person.
Clinical Notes
SOAP notes
DAP notes
AI medical notes